baltimore conference logo
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Maciej Michal Mrugala MD, PhD, MPH | Authors

Articles

Dr. Maciej Michal Mrugala on the Efficacy and Further Uses of Temozolomide in Gliomas

February 09, 2016

Video

Maciej Michal Mrugala MD, PhD, MPH, chief of the Division of Neuro-Oncology, University of Washington